Understanding the Glaukos iStent Infinite® Trials and Their Results
Glaucoma is a vision-threatening disease caused by damage to the optic nerve. It is a condition that affects millions of people worldwide, particularly those over 60 years old. Although there is no cure for glaucoma, there are several treatment options available to control its progression, including eye drops, laser therapy, and surgery. One of the most recent innovations in treating glaucoma is the Glaukos iStent infinite®. In this blog, we will explore the results of the clinical trials for this device and how it could benefit glaucoma patients.
What is the Glaukos iStent Infinite®?
The Glaukos iStent Infinite® is a tiny, FDA-approved device that is surgically implanted into the eye to help reduce intraocular pressure (IOP) caused by glaucoma. This device consists of several microscopic stents that work together to improve the eye’s ability to drain fluid, thereby reducing pressure. The Glaukos iStent Infinite® is a significant improvement over prior versions of the iStent device, which contained only one microscopic stent.
What were the results of the Glaukos iStent Infinite® trials?
Several clinical trials were conducted to assess the safety and efficacy of the Glaukos iStent Infinite®. In a study published in the Journal of Glaucoma, researchers found that patients implanted with the device experienced a significant reduction in IOP throughout the six-month follow-up period. Additionally, patients experienced overall improvement in visual field testing and quality of life measures.
Another trial published in Ophthalmology also showed positive results. Patients with moderate to severe glaucoma were implanted with the Glaukos iStent Infinite®, and their IOP was monitored for up to three years. The results showed that these patients experienced not only lower IOP but also a decrease in the number of glaucoma medications they required.
Who would benefit from using the Glaukos iStent Infinite®?
The Glaukos iStent Infinite® is particularly beneficial for patients with mild to moderate glaucoma who have not responded well to medication or laser therapy. It is also recommended for those who may have difficulty tolerating the side effects of glaucoma medications. Patients who are not good candidates for traditional glaucoma surgery due to their age, general health, or other factors may also find the Glaukos iStent Infinite® to be an effective treatment option.
What are the risks associated with the Glaukos iStent Infinite®?
While the Glaukos iStent Infinite® is generally safe, like any surgical procedure, it does have some risks. These side effects may include irritation, redness, and discomfort in the eye. Additionally, there is a slight chance of infection or bleeding during the implantation procedure. However, these risks are relatively low, and the vast majority of patients who undergo the procedure experience little to no complications.
In conclusion, the Glaukos iStent Infinite® has been shown through clinical trials to be a safe and effective treatment option for patients with mild to moderate glaucoma. It can lower IOP and improve overall quality of life, making it an attractive alternative to more invasive surgeries or medications. While there are some risks associated with the procedure, the majority of patients experience minimal side effects, making it a viable option for glaucoma sufferers seeking relief. If you or a loved one is suffering from glaucoma and would like to explore the possibility of using the Glaukos iStent Infinite®, please speak with your eye doctor to see if this treatment option is right for you.